Nearly half of private company CEOs see US healthcare reform having a notable financial impact on their business

As private company chief executives review the provisions of the USA’s  federal Patient Protection and Affordable Care Act nearly half (47%) of those surveyed for PricewaterhouseCooper's Private Company Trendsetter Barometer say the Act may have a notable financial impact on their business. However, nearly one-third (31%) of respondents believe it's "too soon to tell" how the Act's provisions will impact their companies. 20% don't anticipate a notable financial impact; 2% were unreported. Companies that don't anticipate a notable financial impact are forecasting above-average revenue growth, compared with the other companies surveyed.

PwC's Private Company Trendsetter Barometer incorporates the views of 224 CEOs/CFOs: 125 from companies in the product sector and 99 in the service sector, averaging $256.7 million in enterprise revenue/sales, and including large, $300 million-plus private companies.